文献速递胸部肿瘤放疗放疗物理与技术

高剂量胸部放疗后放射性肺损伤新分级量表预测症状性放射性肺炎

High-dose thoracic radiation therapy for non-small cell lung cancer: a novel grading scale of radiation-induced lung injury for symptomatic radiation pneumonitis.
PubMed 文献 · Radiat Oncol · 2021-07-15

这项前瞻性观察研究纳入41例接受60-66 Gy胸部放疗的非小细胞肺癌患者,评估一种新型放射性肺损伤分级量表(RGS)对症状性放射性肺炎(RP)的预测价值。放疗后约1个月CT显示88%患者存在放射性肺损伤,RGS 2-3级者发生RP的风险显著增高(RR 2.4),且RGS 2-3级预测RP的特异性为100%、敏感性为45.4%。RGS严重程度增加与平均肺剂量及全肺V5相关。

要点

  • 放疗后1个月RGS 2-3级者症状性RP风险显著增高,RR为2.4。
  • RGS 2-3级预测症状性RP特异性100%、敏感性45.4%。
  • RGS严重程度增加与平均肺剂量和全肺V5相关。

核心结论

  • RGS是一种与症状性放射性肺炎相关的简易影像学工具,需验证研究。

研究设计与样本

  • 前瞻性观察研究,纳入41例接受60-66 Gy胸部放疗的非小细胞肺癌患者。
  • 放疗前、放疗后1个月及之后每3个月复查CT至1年,RGS分级0-3,由4名资深放射科医生评估观察者间一致性。

主要发现

  • 放疗后1个月CT显示36例(88%)患者存在放射性肺损伤,RGS 0级5例、1级25例、2级6例、3级5例。
  • RGS分级观察者间一致性高(Kendall's W一致性系数=0.80,p<0.01)。
  • RGS 2-3级患者发生RP的风险显著高于RGS 0-1级(RR 2.4,95%CI 1.6-3.7,p<0.01)。
  • RGS 2-3级患者放疗后8周内出现RP症状的风险显著增高(RR 4.8,95%CI 1.3-17.6,p<0.01)。
  • RGS严重程度增加与平均肺剂量及全肺V5相关。

关键数值与推荐

  • 症状性RP定义为Common Terminology Criteria for Adverse Events grade ≥ 2。
  • RGS分级范围为0至3。
  • RGS 2-3级预测症状性RP的特异性为100%(95%CI 80.5-100%),敏感性为45.4%(95%CI 24.4-67.8%)。

临床怎么用

  • 可利用放疗后约1个月CT的RGS分级辅助识别症状性RP高风险患者。
  • RGS 2-3级提示需加强RP监测,尤其放疗后8周内。

局限性

  • 样本量小(41例),结论需验证研究确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Symptomatic radiation pneumonitis (RP) may be a serious complication after thoracic radiation therapy (RT) for non-small cell lung cancer (NSCLC). This prospective observational study sought to evaluate the utility of a novel radiation-induced lung injury (RILI) grading scale (RGS) for the prediction of RP. MATERIALS AND METHODS: Data of 41 patients with NSCLC treated with thoracic RT of 60-66 Gy were analysed. CT scans were scheduled before RT, one month post-RT, and every three months thereafter for one year. Symptomatic RP was defined as Common Terminology Criteria for Adverse Events grade ≥ 2. RGS grading ranged from 0 to 3. The inter-observer variability of the RGS was assessed by four senior radiologists. CT scans performed 28 ± 10 days after RT were used to analyse the predictive value of the RGS. The change in the RGS severity was correlated to dosimetric parameters. RESULTS: The CT obtained one month post-RT showed RILI in 36 (88%) of patients (RGS grade 0 [5 patients], 1 [25 patients], 2 [6 patients], and 3 [5 patients]). The inter-observer agreement of the RGS grading was high (Kendall's W coefficient of concordance = 0.80, p < 0.01). Patients with RGS grades 2-3 had a significantly higher risk for development of RP (relative risk (RR): 2.4, 95% CI 1.6-3.7, p < 0.01) and RP symptoms within 8 weeks after RT (RR: 4.8, 95% CI 1.3-17.6, p < 0.01) compared to RGS grades 0-1. The specificity and sensitivity of the RGS grades 2-3 in predicting symptomatic RP was 100% (95% CI 80.5-100%) and 45.4% (95% CI 24.4-67.8%), respectively. Increase in RGS severity correlated to mean lung dose and the percentage of the total lung volume receiving 5 Gy. CONCLUSIONS: The RGS is a simple radiologic tool associated with symptomatic RP. A validation study is warranted.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Szejniuk WM, Nielsen MS, Takács-Szabó Z, et al. High-dose thoracic radiation therapy for non-small cell lung cancer: a novel grading scale of radiation-induced lung injury for symptomatic radiation pneumonitis. Radiat Oncol. 2021. PMID: 34266462. doi:10.1186/s13014-021-01857-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。